Aldoxorubicin HCl 2. Ad5 [E1-, E2b -]-CEA 3. Ad5 [E1-, E2b -]-Brachyury 4. Ad5 [E1-, E2b -]-MUC1 5. GI-4014 expressing mutations in RAS at codon 12 (G12V), and codon 61 (Q61R and Q61L); GI-4015 expressing mutations in RAS at codon 12 (G12C), and codon 61 (Q61R and Q61L); GI-4016 expressing mutations in RAS at codon 12 (G12D) and codon 61 (Q61R and Q61L); and GI -4020 expressing mutations in RAS at codon 12 (G12R) and codon 61 (Q61L and Q61H) 6. Recombinant yeast-based vaccine expressing the full length human CEA, with a modified gene coding sequence to code for a single amino acid substitution (asparagine to aspartic acid) at the native protein amino acid position 610 7. Recombinant yeast-based vaccine expressing the human Brachyury oncoprotein 8. NK-92 [CD16.158V, ER IL2] cells 9. N-803, recombinant human superagonist IL -15 com plex (also known as IL -15N72D:IL -15RαSu/IgG1 Fc complex) Approved Products: 10. Avelumab 11.